Role of the integrin-linked kinase (ILK) in determining neuronal polarity  by Guo, Wei et al.
06 (2007) 457–468
www.elsevier.com/locate/ydbioDevelopmental Biology 3Role of the integrin-linked kinase (ILK) in determining neuronal polarity
Wei Guo a,b, Hui Jiang a,b, Virginia Gray c, Shoukat Dedhar c, Yi Rao b,d,⁎
a Institute of Neuroscience, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Graduate School of the Chinese Academy of Sciences,
320 Yueyang Road, Shanghai 200031, China
b National Institute of Biological Sciences, Beijing, 7 Zhongguanchun Life Sciences Park, Beijing 102206, China
c BC Cancer Research Centre, 675 West 10th Avenue, Vancouver, British Columbia, Canada V5Z 1L3
d Department of Neurology, Northwestern University Feinberg School of Medicine, 303 E. Chicago Avenue, Ward 10-185 Chicago, IL 60611, USA
Received for publication 15 November 2006; revised 13 March 2007; accepted 14 March 2007
Available online 20 March 2007Abstract
The establishment of axon–dendrite polarity in mammalian neurons has recently been shown to involve the kinases Akt and GSK-3β. Here we
report the function of the integrin-linked kinase (ILK) in neuronal polarization. ILK distribution is differential: with more of it present in the axonal
tips than that in the dendritic tips of a polarized neuron. Inactivation of ILK by chemical inhibitors, a kinase-inactive mutant or siRNAs inhibited
axon formation, whereas a kinase hyperactive ILK mutant induced the formation of multiple axons. Biochemical studies indicate that ILK is
upstream of Akt and GSK-3β. Manipulations of multiple intracellular components indicate that ILK is functionally upstream of Akt and GSK-3β
but downstream of PI3K in neuronal polarity. These results reveal a key role of ILK in the formation of neuronal polarity and suggest a signaling
pathway important for neuronal polarity.
© 2007 Elsevier Inc. All rights reserved.Keywords: Integrin-linked kinase; Neuronal polarity; Glycogen synthase kinase-3β; Akt; PI3K; Axon determinationIntroduction
Neuronal function relies on its axon–dendrite polarity. Cel-
lular and molecular studies have used cultured pyramidal neu-
rons from the rodent hippocampus as the standard model for
studying mechanisms responsible for neuronal polarization
(Bradke and Dotti, 2000; Craig and Banker, 1994; Horton and
Ehlers, 2003; Wiggin et al., 2005). A hippocampal pyramidal
neuron sends out several initial similar neurites. Later stage, one
of the neurites is clearly longer than the others and is positive for
molecular markers of the axon, whereas the others become the
dendrites (Banker and Cowan, 1977, 1979; Dotti and Banker,
1987; Dotti et al., 1988).
At the subcellular level, neurite competition and centrosomes
have been implicated in axon–dendrite specification (Banker
and Cowan, 1977, 1979; Dotti and Banker, 1987; Dotti et al.,⁎ Corresponding author. Department of Neurology, Northwestern University
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doi:10.1016/j.ydbio.2007.03.0191988; de Anda et al., 2005). Cytoskeleton dynamics is involved
in neuronal polarization (Baas et al., 1988; Bradke and Dotti,
1999). At the molecular level, the evolutionarily conserved
complex Par3, Par6 and atypical PKC has been found to play a
role in neuronal polarization (Nishimura et al., 2004, 2005; Shi
et al., 2003), although not in Drosophila (Rolls and Doe, 2004).
Two small GTPases Rap1b and Cdc42 (Nishimura et al., 2005;
Schwamborn and Puschel, 2004; Shi et al., 2003), and the SAD
kinases (Kishi et al., 2005) are involved in neuronal polarization.
The SAD kinases are the only components that have so far been
found to play a role in neuronal polarization in both invertebrates
(Crump et al., 2001) and vertebrates (Kishi et al., 2005). The
relationship of these intracellular molecules is not clear.
A potential pathway has been suggested by findings of the
roles of Akt and the glycogen synthase kinase-3β (GSK-3β) in
establishing and maintaining neuronal polarity (Jiang et al.,
2005; Shi et al., 2003; Yoshimura et al., 2005). Their down-
stream components include the collapsin response mediator
protein-2 (CRMP-2) (Yoshimura et al., 2005) and adenomatous
polyposis coli (APC) (Shi et al., 2004; Zhou et al., 2004), both
regulators of MT dynamics. The upstream regulators of Akt and
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phosphatase and tensin homolog deleted on chromosome 10
(PTEN) (Jiang et al., 2005; Shi et al., 2003; Yoshimura et al.,
2005). However, none of these upstream molecules can directly
regulate the activity of Akt and GSK-3β, there is therefore a
major gap in this pathway.
PI3K activation leads to Akt phosphorylation at Ser473 and
its activation, which can in turn cause GSK-3β phosphorylation
at Ser9 and its inactivation (Cross et al., 1995). There are several
enzymes implicated as the Ser473 kinase of Akt including
PDK1, Akt itself, ILK, DNA-PKcs and mTOR (Balendran et
al., 1999; Feng et al., 2004; Persad et al., 2001; Sarbassov et al.,
2005; Toker and Newton, 2000). There are also multiple en-
zymes whose activation can directly or indirectly lead to GSK-
3β inactivation, including the MAP kinase (Brady et al., 1998),Fig. 1. Effect of ILK inhibition on Akt and GSK-3β phosphorylation in hippocampa
phosphorylation at Ser9, after treatment with the control vehicle (DMSO), the ILK inh
phosphorylated at Ser473; Akt: total Akt; pGSK-3β (Ser9): GSK-3β phosphorylated
pGSK-3β in the growth cones after treatment with DMSO, 100 μM KP-392 or 50 μ
growth cones. The ratios in growth cones were relative with that in DMSO treated neur
0.03 (n=15), LY294002: 0.33±0.4 (n=15). pGSK-3β/GSK-3β ratios for DMSO:
Statistical analyses were performed between DMSO and ILK inhibitors. Asterisks indp70 ribosomal S6 kinase (p70S6K) (Armstrong et al., 2001),
protein kinase A (PKA) (Fang et al., 2000), protein kinase C
(PKC) (Ballou et al., 2001) and the integrin-linked kinase
(ILK). Our previous studies have failed to find evidence for the
involvement of the MAP kinases, PKA, or PKC in the for-
mation of neuronal polarity (Jiang et al., 2005). We have now
studied the role of ILK because of its potential roles upstream of
both Akt and GSK-3β.
ILK was identified as a β1-integrin cytoplasmic domain
binding protein (Hannigan et al., 1996). It contains four ankyrin
repeats at the amino terminus followed by a pleckstrin homo-
logy (PH) domain and a catalytic domain near the carboxyl
terminus (Hannigan et al., 1996). It can be activated by phos-
phatidylinositol-3,4,5-triphosphate (PIP3) (Delcommenne et al.,
1998; Persad et al., 2001) and can function downstream ofl neurons. (A) Western analysis of Akt phosphorylation at Ser473 and GSK-3β
ibitor KP-392, QLT0267, and the PI3K inhibitor LY294002. pAkt (Ser473): Akt
at Ser9; GSK-3β: total GSK-3β. (B) Immunostaining of Akt, pAkt, GSK-3β and
M LY294002. (C) Quantification of pAkt/Akt and pGSK-3β/GSK-3β ratios in
ons as 1. pAkt/Akt ratios for DMSO treatment: 1.0±0.09 (n=15), KP-392: 0.48±
1.0±0.07 (n=10), KP-392: 0.57±0.03 (n=10), LY294002: 0.41±0.4 (n=10).
icate statistical significance (Student's t test; ***p<0.001).
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Hannigan et al., 2005; Wu and Dedhar, 2001). In vitro bio-
chemical assays and cell biology have shown that ILK could
phosphorylate Akt at Ser473 (Delcommenne et al., 1998; Lynch
et al., 1999; Persad et al., 2001; Troussard et al., 2003), and
GSK-3β at Ser9 (Delcommenne et al., 1998; Lynch et al., 1999;
Persad et al., 2001; Troussard et al., 2003).
These considerations led us to investigate the involvement of
ILK in determining the axon–dendrite polarity and to examine
its functional relationship with the Akt/GSK-3β pathway. We
report here that ILK distribution is preferential in axonal tips of
polarized neurons, that biochemically it is required for phos-
phorylation of Akt at Ser473 and GSK-3β at Ser9 in hippo-
campal neurons, and that ILK is functionally upstream of Akt
and GSK-3β in determining neuronal polarity. These results
demonstrate that ILK is a key component in the signaling path-




Antibodies (and their suppliers) used are: anti-ILK (Upstate and Cell Sig-
naling), anti-Tau-1 (Chemicon), anti-MAP2 (Chemicon), anti-synapsin1 (Che-
micon), anti-GSK-3β (Chemicon and Cell Signaling), anti-phospho-GSK-3βFig. 2. Distribution of ILK in axonal and dendritic tips of hippocampal neurons
Immunocytochemical staining with an anti-ILK antibody (in red) and the anti-Tu
magnification pictures of the tips of axons and dendrites. The scale bar is 20 μm. Note
is not detected in the tips of the dendrites. The white arrows in panel B marked the en
points. (C) Relative ILK levels and ILK/TuJ1 ratios in neurite tips of st. 3 neurons. T
relative level in axons was 4.46±0.40 (n=12). The ILK/TuJ1 ratio in dendrites wa
(n=12). Asterisks indicate statistical significance (Student's t test; ***p<0.001). (D
2 and st. 3 neurons. Fluorescence intensities were measured from the neurites, as sh(Ser9) (Cell Signaling), anti-Akt (Cell Signaling and New England Biolabs), and
anti-phospho-Akt (Ser473) (Cell Signaling).
Chemicals
LY294002 was purchased from Calbiochem and GSK-3β inhibitor
SB415286 from Tocris.
KP-392 (also known as KP-SD-1) was identified in a high-throughput
kinase assay using highly purified recombinant ILK. It has a high degree of
selectivity when tested against 150 protein kinases, and shows greater than 100-
fold selectivity over PDK-1, DNA-PK, GSK-3 and PKB isoforms (unpublished
data). KP-392 has previously been extensively characterized in terms of
inhibiting PKB and GSK-3 phosphorylation in a variety of cell types, including
neurons (Mills et al., 2003; Persad et al., 2001; Troussard et al., 2000).
QLT0267 is a second-generation ILK inhibitor, derived from KP-392. It is
more potent than KP-392 and inhibits ILK kinase activity at 26 nmol/L in a
cell-free assay using highly purified recombinant ILK. It has a similar
selectivity profile to KP-392, but inhibits activation of downstream effectors of
ILK in cells at between 1 and 10 micromolar concentrations. Among 150
kinases tested under similar conditions, QLT0267 is highly specific, showing
∼1000-fold selectivity over kinases including CK2, CSK, DNA-PK, PIM-1,
PKB/Akt and PKC, and ∼100-fold selectivity over other kinases such as Erk-1,
GSK-3β, LCK, PKA, p70S6K, and RSK1 (Troussard et al., 2006; Younes et
al., 2005). The effects of QLT0267 are similar to those of dominant-negative
ILK mutants and siRNA. Furthermore, constitutively active ILK protects the
downstream substrates from inhibition by QLT0267 (Koul et al., 2005; Younes
et al., 2005).
DNA constructs
ILK-WT, ILK-S343A and ILK-S343D were generously provided to us
by Shoukat Dedhar, GSK-3β-S9A/pCS2 was generously provided to us. (A and B) Distribution of ILK in st. 2 and st. 3 rat hippocampal neurons.
J1 antibody (in green). The small panels on the right part of (B) are higher
that, in panel B, ILK staining can be detected in the tip of the axon, whereas ILK
ding points of ILK staining while the staining of TuJ1 is detectable distal to these
he average level of ILK in dendrites was normalized to 1.00±0.14 (n=12). The
s normalized to 1.00±0.06 (n=12). The relative ratio in axons was 1.72±0.12
and E) Fluorescence intensities of anti-ILK immunostaining in the neurites of st.
own in panels A and B.
Fig. 3. Loss of neuronal polarity upon treatment with the inhibitors KP-392 and
QLT0267. (A) The ILK inhibitor KP-392 inhibited the establishment of
neuronal polarity. Neurons were stained with anti-MAP2 (green) and Tau-1
(red). The left panel shows a neuron with normal polarity (with an axon in red
and dendrites in green) in the presence of DMSO. The right panel shows a
neuron without polarity after treatment with 100 μM KP-392: it has 5 dendrites
(staining green for anti-MAP2) but no axons (staining red for Tau-1). (B)
Quantification of polarity defects in neurons treated with DMSO, KP-392 or the
PI3K inhibitor LY294002. DMSO: 81.4±1.1% polarized neurons (n=202);
20 μM KP-392: 50.0±5.0% (n=193); 50 μM KP-392: 33.4±5.3% (n=198);
100 μM KP-392: 20.2±2.2% (n=182); 10 μM LY294002: 56.2±3.5%
(n=119); 50 μM LY294002: 12.6±2.1% (n=155). (C) Quantification of
polarity defects in neurons treated with 100 μMKP-392 and 20 μMQLT0267 in
different time windows. DMSO: 77.3±1.8% polarized neurons (n=226).
100 μM KP-392: 18.4±2.3% (n=313) from 0 to 72 h; 47.8±2.6% (n=216)
from 0 to 24 h; 37.0±0.9% (n=269) from 24 to 48 h; 58.9±2.5% (n=257) from
48 to 72 h. 20 μM QLT0267: 9.0±1.4% (n=273) from 0 to 72 h; 46.2±2.1%
(n=274) from 0 to 24 h; 29.5±3.0% (n=228) from 24 to 48 h; 50.1±1.7%
(n=220) from 48 to 72 h. Statistical analyses were performed between DMSO
and ILK inhibitors. Asterisks indicate statistical significance (Student's t test;
*p<0.05, **p<0.01, ***p<0.001).
460 W. Guo et al. / Developmental Biology 306 (2007) 457–468by P. S. Klein. Myr-HA-Akt/pLNCX was a generous gift from W.R.
Sellers.
Neuronal culture and transfection
Hippocampal neuronal cultures have been described previously (Jiang et al.,
2005). For inhibition of neuronal polarity, the inhibitors were added to the
culture media during medium changes. For Western analysis and ILK inhibition
in neurite tips, all inhibitors were added 5 h before lysis. Transfection of neurons
was carried out immediately after dissociation, using the Amaxa Nucleofector
device following the manufacturer's protocol. Plasmids were co-transfected
with GFP at a ratio of 3:1. After the indicated time points, neurons were fixed
with 4% paraformaldehyde (PFA) in phosphate buffered saline (PBS) at 4 °C for
20 min and processed for immunocytochemistry.
Immunocytochemistry
Fixed neurons were washed with PBS three times for 10 min, and treated
with PBS containing 0.1% Triton X-100 for 10 min. Neurons were then blocked
by 10% normal goat serum in PBS for 1 h at room temperature. After blocking,
neurons were incubated with primary antibodies at 4 °C overnight. After
washing with PBS for 6×5 min, secondary antibodies were added and incubated
at room temperature for 1 h, washed with PBS washing for 6×5 min before
visualization under a fluorescent microscope.
Imaging
Images were acquired with a Zeiss 20× or 40× objective of confocal laser-
scanning microscope. The fluorescence levels were based on single confocal
planes. Images were collected sequentially (multi-track). The excitation lasers
were of 488 nm and 543 nm, and the emission at 505–530 nm and 560–
615 nm. For the relative levels of pAkt and pGSK-3β in Fig. 1C, and ILK in
Fig. 2C, fluorescence intensities were measured in the entire growth cone or
the neurite tip. The ILK fluorescence intensities in Figs. 2D, E are based on
line profiles through the neurites. Morphometric measurements were
performed using the Metamorph software (Universal Imaging) by setting a
threshold of fluorescence intensity and were automatically counted and logged
into Excel.
SiRNAs
Knockdown of ILK was achieved by oligo RNA-based siRNAs. The target
sequence is 5′-CCC CUG AAG CCC UGC AAA A-3′ for ILK-R. The precise
sequences for ILK-R are 5′-CCC CUG AAG CCC UGC AAA ATT-3′ and 5′-
UUU UGC AGG GCU UCA GGG GTT-3′ for rat ILK. The control (non-
targeting) sequences are 5′-UUC UCC GAA CGU GUC ACG UTT-3′ and 5′-
ACG UGA CAC GUU CGG AGA ATT-3′. The relevant sequence of human
ILK is 5′-CCC CCG AAG CUC UGC AGA A-3′ and cannot be targeted by the
designed RNAi. Neurons were transfected using the Amaxa Nucleofector
device. For Western analysis, neurons were harvested 48 h after transfection. For
immunostaining, neurons were fixed 5 days after transfection.
Western analysis
Cells were lysed in the lysis buffer (20 mM HEPES [pH 7.4], 150 mM
NaCl, 1% NP-40, 0.25% sodium deoxycholate, 0.1% SDS, 2 mM EGTA,
1 mM sodium orthovanadate, 1 mM NaF, 1 mM PMSF, 1 μg/ml pepstatin A,
1 μg/ml aprotinin, 1 μg/ml leupeptin). Samples were solubilized with the
loading buffer, heated to 100 °C for 5 min, and resolved by SDS–PAGE using
10% acrylamide. Equal amounts of samples were loaded into discontinuous
gels (10% acrylamide tested under reducing conditions). Proteins were
transferred to PVDF membrane for 1.5 h at 100 V, blocked with 5% BSA
for 1 h at room temperature. Membranes were then incubated with the primary
antibodies in blocking solutions at 4 °C overnight before detection with HRP-
conjugated secondary antibodies. Chemiluminescence was detected with ECL
solution.Results
Requirement of ILK for Akt and GSK-3β phosphorylation in
hippocampal neurons
Biochemically, ILK can phosphorylate Akt at Ser473 and
GSK-3β at Ser9 in vitro or in several cell types (Delcommenne
et al., 1998; Lynch et al., 1999; Persad et al., 2001; Troussard et
al., 2003). We examined whether ILK was required for the
461W. Guo et al. / Developmental Biology 306 (2007) 457–468phosphorylation of Akt and GSK-3β in hippocampal neurons
during the developmental stages when neuronal polarity was
formed.
Hippocampal neurons were isolated from embryonic day 18
(E18) SD rats. We treated cultured neurons with the vehicle
DMSO, or different concentrations of the ILK inhibitor KP-392
(Mills et al., 2003; Persad et al., 2001; Troussard et al., 2000), or
another ILK inhibitor QLT0267 (Troussard et al., 2006; Younes
et al., 2005), or the PI3K inhibitor LY294002. The specificitiesFig. 4. Inhibition of Neuronal Polarity by an ILK siRNA. (A) Neurons transfected w
soma, the entire length of dendrites, and the proximal part of the axon, whereas the axo
Neurons cotransfected with GFP and the ILK siRNA (ILK-R) were stained with dendr
(C) Western analysis showing reduction of ILK protein expression in hippocampal ne
control siRNA. Neurons with no axon: GFP 9.1±0.41% (n=203), Cont 10.1±1.6%
0.93%; Cont 79.2±2.1%, ILK-R 55.9±1.2%. Neurons with multiple axons: GFP 8.7±
Numbers of dendrites in neurons transfected with ILK-R were counted in two categor
GFP (n=47): 1.18±0.08 axons and 4.47±0.22 dendrites. Cont (n=47): 1.17±0.0
dendrites. ILK-R(N) (n=47): 0 axons and 4.44±0.16 dendrites. (F) The average axon
5.4%. Cont (n=66): 99±4.6%. ILK-R(S) (n=67): 77±4.2%. (G) The average dendr
100±6.3%. Cont (n=120): 94±5.6%. ILK-R(S) (n=85): 92±6.6%. ILK-R(N) (n=95
ILK-R effect was rescued by a human wild type ILK cDNA. Quantification of polarity
(n=289), ILK-R+ILK-WT 13.7±1.4% (n=290). Neurons with a single axon: Cont
multiple axons: Cont 11.4±0.36%, ILK-R 8.7±1.9%, ILK-R+ILK-WT 13.2±2
***p<0.001).of the ILK inhibitors have been demonstrated and discussed in
Materials and methods.
Akt phosphorylation at Ser473 and GSK-3β phosphoryla-
tion at Ser9 were detected with specific antibodies. LY294002
served as a positive control because we have previously shown
that it inhibited Akt and GSK-3β phosphorylation (Jiang et al.,
2005) (Fig. 1A). When the extracts from hippocampal neurons
were assayed, the ILK inhibitor KP-392 and QLT0267 both
reduced phosphorylation of Akt at Ser473 and GSK-3β at Ser9ith GFP alone showing normal localization of the dendritic marker MAP2 in the
nal markers Tau-1 and synapsin 1 in the soma and the distal part of the axon. (B)
itic and axonal markers. The axon was lost from neurons transfected with ILK-R.
urons after ILK-R siRNA treatment. (D) Quantification of polarity defects. Cont:
(n=205), ILK-R 36.9±1.8% (n=175). Neurons with a single axon: GFP 82.3±
1.1%, Cont 10.7±1.8%, ILK-R 7.2±0.73%. (E) Number of neurites per neuron.
ies: (S) being neurons with single axons while (N) being neurons with no axons.
6 axons and 4.58±0.23 dendrites. ILK-R(S) (n=47): 1 axons and 4.2±0.20
length of GFP-transfected neurons was normalized as 100%. GFP (n=65): 100±
ite length of GFP-transfected neurons was normalized as 100%. GFP (n=104):
): 139±8.1%. Statistical analyses were performed between Cont and ILK-R. (H)
defects. Neurons with no axon: Cont 11.3±0.80% (n=285), ILK-R 37.6±2.4%
77.4±0.77%, ILK-R 53.7±1.0%, ILK-R+ILK-WT 73.1±2.1%. Neurons with
.3%. Asterisks indicate statistical significance (Student's t test; **p<0.01,
462 W. Guo et al. / Developmental Biology 306 (2007) 457–468(Fig. 1A and Supplementary Fig. 1). Because the functionally
important difference of activity is that in the tips of neurites
(Jiang et al., 2005; Shi et al., 2003), we also examined the
distribution of phospho-Akt and phospho-GSK-3β in the
neurite tips of polarized stage (st.) 3 neurons. Both the ILK
inhibitor KP-392 and the PI3K inhibitor LY294002 decreased
the phosphorylation of both Akt and GSK-3β (Figs. 1B, C).
Distribution of ILK in the neurites of hippocampal neurons
To investigate the significance of ILK in neuronal polarity,
we determined the distribution of ILK in hippocampal neurons
during the developmental stages relevant to neuronal polarity.
Hippocampal neurons from E18 rats were cultured and stained
with a monoclonal antibody specifically recognizing ILK (Mills
et al., 2003) and the TuJ1 antibody recognizing the neuronal-
specific class III β-tubulin.
ILK was found in the tips of all neurites in st. 2 non-polarized
neurons (Figs. 2A, D and Supplementary Fig. 2). However,
there is more ILK present in axonal tips than that in dendritic
tips in st. 3 polarized neurons (Figs. 2B, E and SupplementaryFig. 5. Inhibition of axon formation by a kinase inactive ILK mutant. (A) Neurons
markers. ILK-S343A transfection caused the loss of the axon. (B) Quantification of p
0.77% (n=252), ILK-S343A 37.3±3.9% (n=198). Neurons with a single axon: G
multiple axons: GFP 10.0±1.2%, ILK-WT 16.3±0.40%, ILK-S343A 8.9±0.93%. St
Number of neurites per neuron. The numbers of dendrites of neurons cotransfected w
single axons while (N) being neurons with no axons. GFP (n=44): 1.16±0.08 axon
dendrites. ILK-S343A(S) (n=38): 1 axons and 3.95±0.17 dendrites. ILK-S343A(N)
transfected neurons was normalized as 100%. GFP (n=60): 100±5.2%. ILK-WT (n
length of GFP-transfected neurons was normalized as 100%. GFP (n=149): 100±
S343A(N) (n=91): 152±10%. Asterisks indicate statistical significance (Student's tFig. 2). The relative ILK level and the ILK/TuJ1 ratio in the
axons were both significantly higher than those in dendrites of
the polarized st. 3 neurons (Fig. 2C).
Inhibition of neuronal polarity by an ILK pharmacological
inhibitor, siRNA and a kinase inactive ILK mutant
To study the functional role of ILK, we used three different
ways to inhibit ILK: KP-392 and QLT0267 (two specific
pharmacological inhibitors), ILK-S343A (a kinase inactive ILK
mutant) and small interfering RNA (siRNA) (Persad et al.,
2001). The PI3K inhibitor LY294002 is known to inhibit
neuronal polarization (Shi et al., 2003) and was used as a
positive control. The polarity of neurons were judged both by
the length of longest neurite being 2 times longer than other
neurites and the localization of molecular markers revealed by
immunostaining with specific antibodies. Tau-1 stained the
distal part of axons whereas the anti-MAP2 antibody stained
the entire length of dendrites and the proximal part of axons (as
well as the soma). Synapsin1, which is a presynaptic protein, is
also a marker for axons.transfected with ILK-S343A and GFP were stained with dendritic and axonal
olarity defects. Neurons with no axon: GFP 5.5±0.51% (n=344), ILK-WT 7.7±
FP 84.5±1.6%, ILK-WT 76.0±1.0%, ILK-S343A 53.8±3.1%. Neurons with
atistical analyses were performed between GFP and ILK-WTor ILK-S343A. (C)
ith ILK-S343A and GFP were counted in two categories: (S) being neurons with
s and 4.36±0.20 dendrites. ILK-WT (n=45): 1.27±0.09 axons and 4.24±0.18
(n=42): 0 axons and 4.74±0.17 dendrites. (D) The average axon length of GFP-
=64): 109±6.6%. ILK-S343A(S) (n=62): 71±3.5%. (E) The average dendrite
5.0%. ILK-WT (n=120): 106±6.1%. ILK-S343A(S) (n=91): 91±5.8%. ILK-
test; *p<0.05, **p<0.01, ***p<0.001).
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KP-392 or LY294002 for 3 days. KP-392 increased the
number of neurons without polarity in a dose dependent
manner: axon formation was inhibited by KP-392 (Figs. 3A, B),
as did LY2 94002. We also used another ILK inhibitor
QLT0267 which is more potent than KP-392 and highly
selective for ILK (Koul et al., 2005; Younes et al., 2005). We
found that QLT0267 also inhibited axon formation. There were
only 46.3±3.2% polarized neurons (n=266) treated with 10 μM
QLT0267 relatively to 78.7±1.5% polarized neuron (n=260)
treated with DMSO. To determine whether continuous
treatment for 3 days are required to see the effect, we treated
the hippocampal neurons with the inhibitors in different time
windows and found they affected axon formation and the
establishment of neuronal polarity with 24-h treatment in any
of the first 3 days (Fig. 3C).
We designed a siRNA ILK-R for ILK. It was co-transfected
into rat hippocampal neurons with a cDNA encoding GFP.
Western analysis showed that ILK-R could decrease the level of
ILK efficiently (Fig. 4C). Neurons transfected with siRNAs and
GFP were cultured for 5 days and stained with axonal andFig. 6. Formation of multiple axons in neurons transfected with a hyperactive ILK m
axonal markers. ILK-S343D transfected neurons had multiple axons. (B) Quantificat
WT 7.7±0.77% (n=252), ILK-S343D 5.8±0.37% (n=312). Neurons with a single a
with multiple axons: GFP 10.0± .2%, ILK-WT 16.3±0.40%, ILK-S343D 31.2±0
transfected with GFP and ILK-S343D were counted in two categories: (S) was neuro
1.16±0.08 axons and 4.36±0.20 dendrites. ILK-WT (n=45): 1.27±0.09 axons and
ILK-S343D(M) (n=54): 2.49±0.11 axons and 3.13±0.15 dendrites. (D) The average
100±5.2%. ILK-WT (n=64): 109±6.6%. ILK-S343D(S) (n=61): 125±6.5%. ILK-S
neurons was normalized as 100%. GFP (n=149): 100±5.0%. ILK-WT (n=120): 1
5.8%. Statistical analyses were performed between GFP and ILK-WTor ILK-S343D.
***p<0.001).dendritic markers. To exclude the possibilities that ILK down-
regulation reduced neuronal development or axonal growth, we
analyzed the transfected neurons at day 5, when they were more
mature than those at 3 days. At this stage synapsin1 is an addi-
tional axon marker, although tau-1 could mark axons early at
day 2.
ILK-R could reduce the number of neurons with axons and
increase the number of neurons without axons (Figs. 4A, B for
staining and D for statistics). The number of dendrites was not
affected by ILK siRNAs (Fig. 4E). In neurons whose axons
were still present (ILK-R (S) in Fig. 4F), axon length was
reduced. Only in neurons without axons (ILK-R (N) in Fig.
4G), the length of dendrites was increased. Because the siRNA
ILK-R used here only targets the rat, but not the human, we
used a cDNA expressing the wild type human ILK cDNA to
examine whether the effect caused by siRNA could be rescued
and found that the human ILK cDNA indeed reversed the
phenotype of siRNA (Fig. 4H). Taken together, these results
indicate that ILK siRNAs could inhibit axon formation in two
manners: either completely eliminating axons, or reducing axon
length. The effect on dendrite length was conditional uponutant. (A) Neurons transfected with ILK-S343D were stained with dendritic and
ion of polarity defects. Neurons with no axon: GFP 5.5±0.51% (n=344), ILK-
xon: GFP 84.5±1.6%, ILK-WT 76.0±1.0%, ILK-S343D 62.8±0.32%. Neurons
.32%. (C) Neurite numbers per neuron. Numbers of dendrites of neurons co-
ns with single axons while (M) was neurons with multiple axons. GFP (n=44):
4.24±0.18 dendrites. ILK-S343D(S) (n=60): 1 axon and 4.45±0.14 dendrites.
axon length of GFP-transfected neurons was normalized as 100%. GFP (n=60):
343D(M) (n=77): 69±2.8%. (E) The average dendrite length of GFP-transfected
06±6.1%. ILK-S343D(S) (n=110): 105±6.0%. ILK-S343D(M) (n=88): 98±
Asterisks indicate statistical significance (Student's t test; *p<0.05, **p<0.01,
464 W. Guo et al. / Developmental Biology 306 (2007) 457–468elimination of axons, which is most likely due to a redistribu-
tion of materials that would have been used for axons into the
existing dendrites, as we have previously observed in several
situations with axon elimination (Jiang et al., 2005). All phe-
notypes of ILK siRNAs were similar to the GSK-3β mutant
defective in phosphorylation, consistent with a role for ILK
being upstream of GSK-3β.
Transfection with a kinase inactive ILK ILK-S343A also
increased the number of neurons without axons (Figs. 5A, B).Fig. 7. Functional relationship of ILK with GSK-3β in the formation of neuronal pola
Neurons were stained with dendritic and axonal markers. (B) Quantification of polari
with no axon: GFP 10.4±1.2% (n=222), ILK-S343D 10.4±1.0% (n=228), GSK3
Neurons with a single axon: GFP 78.0±1.6%, ILK-S343D 49.3±1.1%, GSK3β-S9
axons: GFP 11.7±1.1%, ILK-S343D 40.3±1.1%, GSK3β-S9A 9.0±0.64%, ILK-S3
the present of GSK3β inhibitor SB415286 had multiple axons. Neurons were stain
neurons transfected with ILK-S343A in the present of GSK3β inhibitor SB41528
(n=209), GFP+SB41 10.0±0.6% (n=171), ILK-S343A+SB41 17.2±1.8% (n=223
SB41 50.0±3.3%, ILK-S343A+SB41 48.1±0.8%. Neurons with multiple axons: G
SB41 34.8±1.7%. Asterisks indicate statistical significance (Student's t test; ***p<ILK-S343A did not affect the dendrite number (Fig. 5C).
Similar to ILK RNAi treatment, ILK-S343A decreased axon
length in neurons retaining a single axon (ILK-S343A(S) in
Fig. 5D). The dendrites were significantly longer only after the
axon was eliminated by ILK-S343A (ILK-S343A(N) in Fig.
5E). Wild type ILK had a small, but significant, effect on
neuronal polarity (Figs. 5B–E), which is qualitatively similar
to that of the hyperactive ILK-S343D, as will be discussed
below.rity. (A) Neurons cotransfected with ILK-S343D and GSK3β-S9A had no axon.
ty defects in neurons cotransfected with ILK-S343D and GSK3β-S9A. Neurons
β-S9A 39.4±2.0% (n=213), ILK-S343D+GSK3β-S9A 34.8±1.8% (n=249).
A 51.6±1.4%, ILK-S343D+GSK3β-S9A 50.5±1.8%. Neurons with multiple
43D+GSK3β-S9A 14.7±0.92%. (C) Neurons transfected with ILK-S343A in
ed with dendritic and axonal markers. (D) Quantification of polarity defects in
6. Neurons with no axon: GFP 6.9±1.6% (n=234), ILK-S343A 42.4±1.8%
). Neurons with a single axon: GFP 80.1±2.2%, ILK-S343A 48.4±1.5%, GFP+
FP 12.9±1.1%, ILK-S343A 9.2±1.0%, GFP+SB41 40.1±3.1%, ILK-S343A+
0.001).
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siRNAs and the kinase inactive mutant (ILK-S343A) results
in the similar phenotype of axon elimination, indicating that
ILK is required for the formation of the axon, and suggesting
the possibility that ILK could be involved in the establishment
of neuronal polarity.
Induction of multiple axons by a kinase hyperactive ILK mutant
To investigate the effect of ILK activation, we used ILK-
S343D, a kinase hyperactive ILK mutant (Persad et al., 2001).
ILK-S343D increased the number of neurons with multiple
axons, but decreased the number of neurons with a single axon
(Figs. 6A, B). The total number of neurites per neuron was not
significantly changed, indicating that the formation of multiple
axons was at the expense of dendrites (Fig. 6C). In neurons
transfected with ILK-S343D that still had a single axon, the
axons were longer than those transfected with GFP alone (ILK-Fig. 8. Functional relationship of ILK with Akt and PI3K in the formation of neuronal
axons. Neurons were stained with dendritic and axonal markers. (B) Quantificatio
Neurons with no axon: GFP 10.5±1.2% (n=242), ILK-S343A 41.1±1.4% (n=227
Neurons with a single axon: GFP 78.1±0.76%, ILK-S343A 48.3±1.1%, Myr-Akt 5
GFP 11.5±0.52%, ILK-S343A 10.6±0.95%, Myr-Akt 40.0±2.1%, ILK-S343A+M
CAAX had no axon. Neurons were stained with dendritic and axonal markers. (D) Q
P110-CAAX. Neurons with no axon: GFP 10.5±1.2% (n=242), ILK-S343A 41.1±
35.7±1.7% (n=258). Neurons with a single axon: GFP 78.1±0.76%, ILK-S343A
Neurons with multiple axons: GFP 11.5±0.52%, ILK-S343A 10.6±0.95%, P110-C
statistical significance (Student's t test; ***p<0.001).S343D(S) in Fig. 6D). The length of axons was shorter when
multiple axons formed (ILK-S343D(M) in Fig. 6D). The length
of dendrite was not affected by ILK-S343D transfection (Fig.
6E). These results indicate that ILK activation causes the
formation of multiple axons and promote the growth of single
axons. These results are similar to GSK-3β inactivation (Jiang
et al., 2005). Akt activation also causes the formation of
multiple axons, but it also increases the total number of neurites
(Jiang et al., 2005). ILK-S343D cannot mimic the effect of Akt
activation on the total number of neurites.
Functional relationship of ILK to GSK-3β, Akt, and PI3K
To determine the functional relationship between ILK and
another molecule in the formation of neuronal polarity, we
manipulated the activities of both ILK and the other molecule
and examined whether the phenotype of manipulating one
molecule (X) predominated over the phenotype of manipulatingpolarity. (A) Neurons co-transfected with ILK-S343A andMyr-Akt had multiple
n of polarity defects in neurons cotransfected with ILK-S343A and Myr-Akt.
), Myr-Akt 9.2±0.67% (n=232), ILK-S343A+Myr-Akt 13.9±1.0% (n=247).
0.8±2.6%, ILK-S343A+Myr-Akt 49.7±0.96%. Neurons with multiple axons:
yr-Akt 36.4±0.43%. (C) Neurons cotransfected with ILK-S343A and P110-
uantification of polarity defects in neurons cotransfected with ILK-S343A and
1.4% (n=227), P110-CAAX 9.9±0.94% (n=218), ILK-S343A+P110-CAAX
48.3±1.1%, P110-CAAX 52.2±1.1%, ILK-S343A+P110-CAAX 49.2±1.2%.
AAX 37.8±1.7%, ILK-S343A+P110-CAAX 15.1±0.76%. Asterisks indicate
Fig. 9. A model for ILK signaling in neuronal polarity. AKT/GSK-3β pathway
is thought to regulate neuronal polarity through CRMP2, APC and MAP1b. ILK
functions downstream of the PI3K but upstream of Akt and GSK-3β in
determining neuronal polarity. It is not known whether extracellular ligands can
function through transmembrane receptors such as integrins or tyrosine kinase
receptors in neuronal polarization.
466 W. Guo et al. / Developmental Biology 306 (2007) 457–468another molecule (Y). If phenotypic predomination occurs, it
would support an epistatic relationship between X and Y, with X
being downstream of Y.
Because the phenotype of ILK activation is opposite to GSK-
3β activation, the relationship of ILK and GSK-3β was
determined by two experiments: one by increasing the activities
of both ILK and GSK-3β, the other by decreasing the activities
of both ILK and GSK-3β. As shown previously, the
constitutively active ILK-S343D increased the percentage of
neurons with multiple axons and decreased the percentage of
neurons with a single axon. A constitutively active GSK-3β
mutant GSK3β-S9A increased the percentage of neurons with
no axon and decreased the percentage of neurons with a single
axon (Jiang et al., 2005). When both the constitutively active
ILK (ILK-S343D) and the constitutively active GSK-3β (GSK-
3β-S9A) were introduced into hippocampal neurons, the
predominant phenotype was that of GSK-3β-S9A (Figs. 7A,
B). The GSK-3β inhibitor SB415286 induced multiple axons
(Jiang et al., 2005), whereas the kinase inactive ILK mutant
ILK-S343A inhibited axon formation. When both ILK and
GSK-3β were inhibited (by the introduction of ILK-S343A and
SB415286) in hippocampal neurons, the phenotype was that of
the GSK-3β inhibitor SB415286 (Figs. 7C, D). Thus, in both
types of experiments, the effects of manipulating GSK-3β
activity predominate over those of ILK manipulation, indicating
that that ILK acts upstream of GSK-3β.
To study the functional relationship between ILK and Akt,
we used the kinase inactive ILK mutant S343A and the
constitutively active Akt mutant myr-Akt, derived by Akt
fusion with the myristoylation signal of Src (Ramaswamy et al.,
1999). It was not possible to do the complementary experi-
ments of inhibiting Akt and activating ILK because Akt
inhibition caused neuronal death (Jiang et al., 2005), precluding
studies of Akt inhibition on neuronal polarity. As shown pre-
viously (Jiang et al., 2005), myr-Akt increased both the number
of axons per neuron and the number of dendrites per neuron.
Here we found that myr-Akt phenotype predominated over that
of ILK-S343A in increasing axons and dendrites (Figs. 8A, B).
These results are consistent with the idea of Akt being down-
stream of ILK.
To determine the relationship between ILK and PI3K, we
used P110-CAAX, a constitutively active form of the catalytic
subunit of PI3K (Hu et al., 1995). P110-CAAX alone induced
multiple axons formation, similar to the hyperactive ILK
mutant S343D. When P110-CAAX was introduced together
with the kinase inactive ILK mutant ILK-S343A, the phenotype
of the latter predominated over that of P110-CAAX: the
percentage of neurons with multiple axons decreased while that
with no axon increased (Figs. 8C, D). These results indicate
that ILK is downstream of PI3K in determining neuronal
polarity.
Discussion
Our results have led to two conclusions. First, ILK plays an
important role in determining the axon–dendrite polarity of
hippocampal pyramidal neurons. Second, ILK functions down-stream of the PI3K but upstream of Akt and GSK-3β. ILK is
therefore an important link in the signaling pathway involved in
the formation of neuronal polarity (Fig. 9).
Support for the first conclusion came from our studies of ILK
distribution and function. ILK is present in all neurites at st. 2
but preferentially present in the tips of the axons at st. 3.
Inhibition of ILK activity by three different methods (a
pharmacological inhibitor, a kinase inactive construct, and
siRNAs) all result in inhibition of the axon formation but did not
affect dendrite formation. A kinase hyperactive ILK induces the
formation of multiple axons with concomitant reduction of
dendrites.
Support for the second conclusion came from biochemical
and functional studies of the relationship of ILK with other
signaling molecules. The distribution of ILK reported here is
similar to those of phosphorylated Akt and phosphorylated
GSK-3β in hippocampal pyramidal neurons (Jiang et al.,
2005; Shi et al., 2003; Yoshimura et al., 2005). Inhibition of
ILK activity reduced phosphorylation of Akt and GSK-3β.
The phenotype of manipulating ILK activity can be over-
ridden by that of Akt and GSK-3β, indicating that ILK is
functionally upstream of Akt and GSK-3β. On the other
hand, manipulating ILK activity can override the phenotype
of changing PI3K activity, indicating that ILK is downstream
of the PI3K.
It is presently unclear whether ILK directly regulates only
Akt and then indirectly regulates GSK-3β, or that it directly
regulates both Akt and GSK-3β. Biochemically, both possibi-
lities remain plausible because phosphorylation of both Akt and
GSK-3β were reduced in hippocampal neurons after ILK
inhibition. In several cell types, ILK inhibitor reduced Ser473
phosphorylation of Akt and Ser9 phosphorylation of GSK-3β
(Mills et al., 2003; Persad et al., 2001; Zhou et al., 2004).
467W. Guo et al. / Developmental Biology 306 (2007) 457–468Purified ILK protein can phosphorylate Akt at Ser473 and
GSK-3β directly in vitro (Delcommenne et al., 1998; Persad et
al., 2001). ILK or its hyperactive mutant increased Akt
phosphorylation. The dominant negative ILK and ILK siRNAs
reduced Akt and GSK-3β phosphorylation (Delcommenne
et al., 1998; Lynch et al., 1999; Persad et al., 2001; Troussard
et al., 2003). Conditional knockout of ILK in vitro decreased
phosphorylation of Akt and GSK-3β in mouse macrophages
(Troussard et al., 2003). Deletion of ILK inhibited Akt
phosphorylation stimulated by PDGF but not that by insulin
(Sakai et al., 2003). Western analysis of brain extracts showed
that phosphorylation of Akt and GSK-3β were not affected in
the forebrain of ILK knockout mice (Niewmierzycka et al.,
2005), although Akt and GSK-3β phosphorylation in the tips of
axons and dendrites have not been examined.
ILK is associated with other molecules, some of which are
implicated in neuronal polarization. Its ankyrin domains bind to
a number of adaptor and signalling molecules, such as PINCH
and the ILK-associated phosphatase (ILKAP) (Leung-Hages-
teijn et al., 2001; Tu et al., 1999). PINCH can interact with Nck-
2, an adaptor protein containing three Src homology (SH)3
domains and one SH2 domain, which could be potentially
linked to phosphorylated tyrosine of growth factor receptors (Tu
et al., 1998). Because a specific inhibitor for growth factor
receptor tyrosine kinase (RTK), AG1478, prevented neurons
from becoming polarized (Shi et al., 2003), it raises the
possibility of a potential linkage between RTK and ILK in the
determination of neuronal polarity.
ILK is also linked to other proteins ranging from the trans-
membrane integrins to the cytoplasmic α-parvin (ILKBP),
β-parvin (affixin), paxillin (Nikolopoulos and Turner, 2001; Tu
et al., 2001; Wu and Dedhar, 2001; Yamaji et al., 2001) and α-
PIX (Rosenberger et al., 2003), a guanine nucleotide exchange
factor for Rac1 and Cdc42, which are key regulators of actin
dynamics. ILK can also directly phosphorylate myosin light
chain (MLC) or inactivate the myosin phosphatase target
subunit, leading to further stimulation of MLC phosphorylation
(Deng et al., 2001; Muranyi et al., 2002), which is also
implicated in multiple axons formation (Kim and Chang, 2004).
Our finding of a role for ILK in neuronal polarity makes it
interesting to delineate the roles and interactions among the ILK
interacting proteins in the neuronal polarity.
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